慢性肝病功能性肝脏影像评分与肝细胞功能及疾病严重度的关联
结果显示FLIS与Child-Pugh分级显著相关,主要反映肝细胞功能;而FIB-4和脾脏大小与总体疾病严重度关联更强。
要点
- FLIS主要反映肝细胞功能,尤其与Child-Pugh分级相关
- FIB-4和脾脏大小比FLIS更能反映总体疾病严重度
- FLIS可作为肝细胞功能的补充影像生物标志物,但不能替代Child-Pugh和FIB-4
核心结论
- FLIS与肝细胞功能指标尤其是Child-Pugh分级显著相关
- FIB-4和脾脏大小与总体疾病严重度的关联强于FLIS
- FLIS可作为肝细胞功能的补充影像生物标志物,不宜替代Child-Pugh和FIB-4等临床指标
研究设计与样本
- 根据疾病严重度分为非ACLD、代偿性ACLD和失代偿性ACLD三组,同时按Child-Pugh分级和FIB-4评分分类
- 从肝胆期图像计算FLIS、相对肝脏强化(RLE)和肝脾指数(LSI)
关键影像表现/征象
- FLIS各组成部分中,仅肝胆期肝实质强化在疾病严重度组间存在显著差异
- FLIS与RLE和LSI均呈正相关(均p<0.001)
诊断标准与关键数值
- Child-Pugh分级和FIB-4评分均与疾病严重度显著相关(均p<0.001)
- FLIS与Child-Pugh分级显著相关(p<0.001),肝功能保留较好的患者FLIS评分更高
- 效应量分析显示FIB-4和脾脏大小与疾病严重度的关联强于FLIS
临床应用与阅片要点
- 日常阅片中FLIS可用于辅助评估肝细胞功能,尤其在Child-Pugh分级基础上提供影像学补充信息
- 评估总体肝病严重度时,应优先参考FIB-4和脾脏大小等指标,FLIS不应单独用于疾病分期
局限性
- 回顾性观察性研究设计
- 单中心研究
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the association of the Functional Liver Imaging Score (FLIS), derived from gadoxetic acid-enhanced MRI (GA-MRI), with clinical and imaging markers of liver function and disease severity in patients with chronic liver disease (CLD), and to determine whether FLIS primarily reflects hepatocellular function or overall disease severity.
METHODS: Ninety-four patients with CLD who underwent GA-MRI between January 2023 and June 2025 were retrospectively analyzed. FLIS, Relative Liver Enhancement (RLE), and Liver-to-Spleen Index (LSI) were calculated from hepatobiliary-phase images. Patients were classified according to disease severity (non-ACLD, cACLD, and dACLD), Child-Pugh class, and FIB-4 score. Associations among FLIS, quantitative imaging parameters, and clinical severity markers were evaluated using correlation and group-comparison analyses.
RESULTS: Both Child-Pugh class and FIB-4 score were significantly associated with disease severity (p < 0.001). FLIS demonstrated a significant association with Child-Pugh class (p < 0.001), with higher scores observed in patients with better preserved liver function. Among FLIS components, hepatobiliary-phase parenchymal enhancement differed significantly across disease severity groups. FLIS correlated positively with RLE and LSI (both p < 0.001). Effect size analysis showed that FIB-4 and spleen size had stronger associations with disease severity than FLIS.
CONCLUSION: FLIS was associated primarily with markers of hepatocellular function, particularly Child-Pugh class, whereas FIB-4 and spleen size showed stronger relationships with overall disease severity. These findings suggest that FLIS may be used as a complementary imaging biomarker of hepatocellular function, but should not replace established clinical indices such as Child-Pugh and FIB-4.
TRIAL REGISTRATION: Not applicable. This study is a retrospective observational study and did not involve a prospective health care intervention.
引用
- Can, Karaalioğlu, Kahraman, et al. Functional liver imaging score in chronic liver disease: association with hepatocellular function and disease severity markers. Abdom Radiol (NY). 2026. PMID: 42489913. doi:10.1007/s00261-026-05708-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。